These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3908845)

  • 1. [Pancreatic beta cell function in patients treated with continuous ambulatory peritoneal dialysis. Its evolution in time and its relation with metabolic complications].
    Selgas R; Albero R; Muñoz J; Grande C; Beberide JM; Huarte E; Fontán MP; Miguel JL; Torre A; Sicilia LS
    Med Clin (Barc); 1985 Oct; 85(12):491-4. PubMed ID: 3908845
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorption and biological effect of intraperitoneal insulin administration in patients with terminal renal failure treated by continuous ambulatory peritoneal dialysis (CAPD).
    Peetoom JJ; Willekens FL; Meinders AE
    Neth J Med; 1985; 28(10):435-41. PubMed ID: 3908952
    [No Abstract]   [Full Text] [Related]  

  • 3. Nutritional and metabolic studies in children on continuous ambulatory peritoneal dialysis.
    Broyer M; Niaudet P; Champion G; Jean G; Chopin N; Czernichow P
    Kidney Int Suppl; 1983 Nov; 15():S106-10. PubMed ID: 6368945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose, insulin and C-peptide kinetics during continuous ambulatory peritoneal dialysis.
    Wideröe TE; Smeby LC; Myking OL; Wessel-Aas T
    Proc Eur Dial Transplant Assoc; 1983; 20():195-200. PubMed ID: 6361735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interrelationship of dialysate glucose and lactate in continuous ambulatory peritoneal dialysis (CAPD).
    Yamamoto T; Yamakawa M; Kishimoto T; Senju M; Hashinaka Y; Midzutani Y; Hirata S; Horiuchi N; Maekawa M
    Trans Am Soc Artif Intern Organs; 1985; 31():595-8. PubMed ID: 3837515
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Continuous ambulatory peritoneal dialysis in treating chronic kidney failure].
    Robeva R; Belovezhdov N
    Vutr Boles; 1981; 20(4):9-13. PubMed ID: 7029909
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment by continuous ambulatory peritoneal dialysis for chronic renal insufficiency in the diabetic].
    Rottembourg J; Issad B; Allouache M; Diab R; Hamani A; Jacobs C
    Nephrologie; 1995; 16(1):111-21. PubMed ID: 7700411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical changes with continuous ambulant peritoneal dialysis (CAPD)].
    Fuchs C; Armstrong VW; Dorn D; Ebert R; Scheler F
    Z Urol Nephrol; 1982 Jun; 75(6):415-27. PubMed ID: 6750973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma glucose, serum insulin and C-peptide in patients with various stages of chronic renal failure].
    Jovanović D; Djukanović Lj; Veljović R; Manojlović D
    Srp Arh Celok Lek; 1994; 122(3-4):59-61. PubMed ID: 17972808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma insulin, glucose and C-peptide responses to oral glucose tolerance test in patients with liver disease].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):657-61. PubMed ID: 6819876
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glucose intolerance in patients with chronic renal failure].
    Yokota M; Hara S; Matsushita Y
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():739-45. PubMed ID: 12238129
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic aspects of continuous ambulatory peritoneal dialysis with reference to energy-protein input and growth.
    De Santo NG; Capodicasa G; Gilli G; Di Leo VA; Capasso G; Giordano C
    Int J Pediatr Nephrol; 1982 Dec; 3(4):279-86. PubMed ID: 6762357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pancreatic beta-cell function in Itsenko-Cushing disease].
    Slavnov VN; Komissarenko IV; Eremenko NI
    Vrach Delo; 1983 Nov; (11):79-82. PubMed ID: 6362198
    [No Abstract]   [Full Text] [Related]  

  • 17. Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders.
    Tura A; Pacini G; Kautzky-Willer A; Ludvik B; Prager R; Thomaseth K
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E155-62. PubMed ID: 12670835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of pancreatic graft function.
    Gunnarsson R; Arner P; Lundgren G; Ostman J; Groth CG
    Transplant Proc; 1980 Dec; 12(4 Suppl 2):107-11. PubMed ID: 7013185
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
    Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
    J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
    Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.